We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Imprimis Pharmaceuticals (IMMY) Jumps: Stock Rises 10%
Imprimis Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $2.32 to $2.56 in the past one-month time frame.
The company has seen one positive estimate revision in the last 30 days and the Zacks Consensus Estimate also moved higher suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
Imprimis Pharmaceuticals currently carries a Zacks Rank #2 (Buy).
Imprimis Pharmaceuticals, Inc. Price
Imprimis Pharmaceuticals, Inc. Price | Imprimis Pharmaceuticals, Inc. Quote
Another favorably placed stock in the same industry is Quidel Corporation (QDEL - Free Report) , flaunting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is IMMY going up? Or down? Predict to see what others think: Up or Down
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017? Who wouldn't? Last year's market-beating Top 10 portfolio produced 5 double-digit winners. For example, oil and natural gas giant Pioneer Natural Resources and First Republic Bank racked up stellar gains of +44.9% and +44.3% respectively. Now a brand-new list for 2017 has been hand-picked from 4,400 companies covered by the Zacks Rank. See the 2017 Top 10 right now>>